Danica Pension Livsforsikringsaktieselskab Acquires New Position in Cigna Group $CI

Danica Pension Livsforsikringsaktieselskab bought a new position in shares of Cigna Group (NYSE:CI) during the first quarter, HoldingsChannel.com reports. The firm bought 26,084 shares of the health services provider’s stock, valued at approximately $6,958,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Wilkerson Advisory Group LLC purchased a new position in shares of Cigna Group during the 4th quarter worth $25,000. Beacon Financial Strategies CORP acquired a new stake in shares of Cigna Group during the fourth quarter worth $28,000. Kemnay Advisory Services Inc. purchased a new stake in shares of Cigna Group in the fourth quarter valued at $29,000. Prosperity Bancshares Inc acquired a new position in Cigna Group in the fourth quarter valued at $29,000. Finally, Cedar Mountain Advisors LLC increased its stake in Cigna Group by 161.9% in the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 68 shares during the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Trading Down 1.8%

NYSE CI opened at $285.29 on Thursday. Cigna Group has a one year low of $239.51 and a one year high of $315.47. The company’s 50 day moving average price is $286.11 and its 200 day moving average price is $280.66. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The firm has a market capitalization of $75.47 billion, a price-to-earnings ratio of 12.09, a PEG ratio of 1.12 and a beta of 0.29.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. During the same quarter in the prior year, the business earned $6.74 earnings per share. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, sell-side analysts predict that Cigna Group will post 30.39 EPS for the current year.

Insider Buying and Selling at Cigna Group

In other news, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their position. The SEC filing for this sale provides additional information. 0.60% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

CI has been the topic of several recent analyst reports. Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, June 20th. Raymond James Financial set a $340.00 price target on Cigna Group in a report on Friday, May 1st. Royal Bank Of Canada upped their price objective on shares of Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a research note on Friday, May 1st. Robert W. Baird set a $337.00 price objective on shares of Cigna Group in a report on Friday, May 1st. Finally, Guggenheim raised their target price on shares of Cigna Group from $334.00 to $338.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $338.80.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.